Part E Price Negotiation Program To Lower Prices for Certain High-Priced Single Source Drugs

Sections in Part E

• § 1320f Establishment of program
• § 1320f–1 Selection of negotiation-eligible drugs as selected drugs
• § 1320f–2 Manufacturer agreements
• § 1320f–3 Negotiation and renegotiation process
• § 1320f–4 Publication of maximum fair prices
• § 1320f–5 Administrative duties and compliance monitoring
• § 1320f–6 Civil monetary penalties
• § 1320f–7 Limitation on administrative and judicial review